Your SlideShare is downloading. ×
0
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Anxiolytic new
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Anxiolytic new

249

Published on

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
249
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
26
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Pharmacology PHARMA BOARD
  • 2. Anxiety  Fear, apprehension and worry  Accompanied by physical sensations such as anxiety, nausea, chest pain and/or shortness of breath
  • 3. Neurotransmitters  Excitatory NTs  Key words: sodium, calcium, depolarization  Inhibitory NTs  Key: chloride, GABA, hyperpolarization
  • 4. Excitatory neurotransmitters  opens Na or Ca channels/ influx depolarization (more positive) nerve impulse  e.g. Norepinephrine, Dopamine, Acetylcholine, Glutamate, Aspartate
  • 5. Inhibitory neurotransmitters  opens Cl channels hyperpolarization (more negative)  no nerve impulse  e.g. glycine, gamma-aminobutyric acid (GABA)
  • 6.  1. Panic disorder- recurrent unexpected panic attacks that can occur with agoraphobia in which patients fear places in which escape might be difficult.  2. Specific phobia- intense fear of particular objects or situations (e.g. snakes, heights);most common psychiatric disorder
  • 7.  3. Social phobia-intense fear of being scrutinized in social or public situations (e.g., giving a speech, speaking in class).  4. Generalized anxiety disorder- intense pervasive worry over virtually every aspect of life
  • 8.  5. Post-traumatic stress disorder- persistent reexperience of a trauma, efforts to avoid recollecting the trauma, and hyperarousal  6. Obsessive-compulsive disorder- recurrent obsessions and compulsions that cause significant distress and occupy a significant portion of one’s life
  • 9. Sedatives-Hypnotics  Benzodiazepines  Increase the frequency of GABA-mediated chloride ion channel opening  Barbiturates  Increase the duration of GABA-mediated chloride ion channel opening
  • 10. Classes of Anxiolytic and Hypnotic drug Benzodiazepines  5-HT1A-receptor agonists  β-adrenoceptor antagonists
  • 11. Benzodiazepines  Act by binding to a specific regulatory site on the GABA A-receptor  enhances the inhibitory effect of GABA.  Subtypes of the GABA A-receptor exist in different regions of the brain  differ in their sensitivity to benzodiazepines.  Anxiolytic benzodiazepines are agonists at this regulatory site.
  • 12. Receptor Empty Intra cellular GABA GABA Receptor - CL +++++++ - - - - - NaChannel NaChannel
  • 13. Intra cellular GABA GABA Receptor - CL + + + + - - - - NaChannel NaChannel - - - -
  • 14. Use of The Drugs Clinical indications for the use of the anxiolytics, sedatives and hypnotics  1. Prevention of anxiety  2. Formation of sedative state  3. Induction of sleep
  • 15. ACTIONS  Reduction of anxiety  Sedative – hypnotics  Anticonvulsant  Muscle relaxant
  • 16. The BENZODIAZEPINES The benzodiazepines are the most frequently used anxiolytic drugs. These agents prevent anxiety states without causing much sedation, with less physical dependence than other agents.
  • 17. The BENZODIAZEPINES  Long Acting  Intermediate Acting  Short Acting
  • 18. Long Acting (1-3 days)  Charlie Chaplein Died From Q-fever
  • 19. Long Acting (1-3 days)  Charlie - Chlorazepate  Chaplein - Chlordiazepoxide  Died - Diazepam  From - Flurazepam  Q-fever - Quazepam
  • 20. Intermediate  L A T E
  • 21. Intermediate  L - Lorazepam  A - Alprazolam  T - Temazepam  E - Estazolam
  • 22. Short Acting  O- Oxazepam  T- Triamzolam
  • 23.  Uses:  Anxiety- alprazolam, diazepam  Seizures- diazepam, clonazepam, lorazepam  Insomnia- flurazepam, midazolam  Pre-operative sedation- midazolam
  • 24. The BENZODIAZEPINES Special uses Diazepam (Valium) Status epilepticus Chlordiazepoxide (Librium) Alcohol withdrawal Alprazolam (Xanax) Panic attack
  • 25. The BENZODIAZEPINES These agents are indicated for the treatment of 1. anxiety disorders 2. alcohol withdrawal 3. hyperexcitability, and agitation 4. pre-operative relief of anxiety and tension and in induction of balanced anesthesia.
  • 26. The BENZODIAZEPINES Pharmacodynamics: The adverse effects  CNS effects= drowsiness, depression, lethargy, blurred vision  GIT= dry mouth, constipation, nausea, vomiting . sedation,
  • 27.  CVS= Hypotension or hypertension, arrhythmias, palpitations, and respiratory difficulties.  Hematologic= blood dyscrasias and anemia  GU= urinary retention, hesitancy, loss of libido and sexual functions changes.
  • 28. The BENZODIAZEPINES  Instruct to avoid consuming ALCOHOL while taking the drug.
  • 29. The BENZODIAZEPINES  Have available FLUMAZENIL as an antidote for benzodiazepine overdose.
  • 30. 5-HT1A Agonists as Anxiolytic Drugs  Buspirone  potent (though non-selective) agonist at 5HT1A- receptors.  Lacks anti-seizure and muscle relaxant properties as benzodiazepines  Headache, minimal tolerance and withdrawal  Anxiolytic effects take days or weeks to develop.  Ipsapirone and Gepirone are similar.  Side effects include dizziness, nausea, headache, but not sedation or loss of coordination
  • 31. The BARBITURATES  These are also anxiolytics and hypnotics with a greater likelihood of producing sedation, with increase risk of addiction and dependence.
  • 32. Barbiturates Non-selective CNS depressants Sedation and unconsciousness Bind to the GABA receptor and enhances activity potent inducers of hepatic drug- metabolising enzymes Tolerance and dependence occur.
  • 33. Barbiturates Non-selective CNS depressants Sedation and unconsciousness Bind to the GABA receptor and enhances activity potent inducers of hepatic drug- metabolising enzymes Tolerance and dependence occur.
  • 34. MODE OF ACTION  Interferes with Na and K transport  Potentiates GABA action on Cl
  • 35. ACTIONS  Depression of CNS  Respiratory depression  Enzyme induction
  • 36. CLASSIFICATION  ULTRA – SHORT  Thiopental  Thiamylal  Methohexital  Duration: 30min
  • 37.  SHORT ACTING  Hexobarbital  Pentobarbital  Secobarbital  Duration: 2hrs
  • 38.  INTERMEDIATE ACTING  Amobarbital  Butabarbital  Duration: 3 – 5hra
  • 39.  LONG ACTING  Barbital  Phenobarbital  Duration: > 6hrs
  • 40. The BARBITURATES Pharmacodynamics: The Adverse effects  CNS= CNS depression, somnolence, vertigo, lethargy, ataxia, paradoxical excitement, anxiety and hallucinations.  GIT= nausea, vomiting, constipation/diarrhea and epigastric pain
  • 41.  CVS= bradycardia, Hypotension and syncope.  Respi= serious hypoventilation, respiratory depression and laryngospasms  Others= hypersensitivity and Stevens- Johnson syndrome.
  • 42. Other Notes  Benzodiazepines have no analgesic properties  Fatality of alcohol and benzodiazepines  Hypnotics does not induce REM so less restful than normal sleep  Longer acting drugs are easier to dose so effective in alcohol withdrawal
  • 43. Sedative-Hypnotics: Barbiturates Drug Interactions  Additive effects:  ETOH, antihistamines, benzodiazepines, narcotics, tranquilizers  Inhibited metabolism:  MAOIs will prolong effects of barbiturates  Increased metabolism:  Reduces anticoagulant response, leading to possible clot formation
  • 44. Benzodiazepines vs. Barbiturates Criteria BZ Barb. Relative Safety High Low Maximal CNS depression Low High Respiratory Depression Low High Suicide Potential Low High Abuse Potential Low High Antagonist Available? Yes No
  • 45. Ion channel that contains the GABA receptor: A. sodium B. calcium C. chloride D.potassium
  • 46. Anxiolytic drug acting through serotonin receptors: A.diazepam (Valium) B. buspirone (BuSpar) C. triazolam (Halcion) D. phenobarbital
  • 47. A comatose patient is brought to the emergency department with severe respiratory depression caused by diazepam overdosage. Reasonable intervention at this point include: A. administer naloxone (Narcan) to block the drug's effect at the receptor B. provide supportive therapy until the drug effect wears off. C. administer flumazenil D. B & C
  • 48. Short-acting benzodiazepine A. diazepam (Valium) B. flurazepam (Dalmane) C. triazolam (Halcion) D. buspirone (BuSpar)
  • 49. Most useful in reversing symptoms of benzodiazepine overdosage: A. amphetamine B. buspirone (BuSpar) C.flumazenil (Romazicon) D. naltrexone (ReVia)

×